Comparison of two adjuvant hormone therapy regimens in patients with high-risk localized prostate cancer after radical prostatectomy: primary results of study CU1005

Comparison of two adjuvant hormone therapy regimens in patients with high-risk localized prostate cancer after radical prostatectomy: primary results of study CU1005

The role of adjuvant hormonal therapy and optimized regimens for high-risk localized prostate cancer after radical prostatectomy remains controversial. Herein, the clinical trial CU1005 prospectively evaluated two regimens of maximum androgen blockage  or bicalutamide 150 mg daily as immediate adjuv...

Descrizione completa

Dettagli Bibliografici
Autori principali: Kun Chang, Xiao-Jian Qin, Hai-Liang Zhang, Bo Dai, Yao Zhu, Guo-Hai Shi, Yi-Jun Shen, Yi-Ying Zhu, Ding-Wei Ye
Natura: Articolo
Lingua:English
Pubblicazione: Wolters Kluwer Medknow Publications 2016-01-01
Serie:Asian Journal of Andrology
Soggetti:
adjuvant; bicalutamide; high-risk; maximum androgen blockage; prostate cancer; radical prostatectomy
Accesso online:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=3;spage=452;epage=455;aulast=Chang

Accesso online

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=3;spage=452;epage=455;aulast=Chang

Documenti analoghi